The Company (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended		139 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Dec. 31, 2014	Sep. 19, 2014
Common stock outstanding shares	5,000,000		5,000,000		5,000,000
Common stock issued and outstanding per share	$ 0.001		$ 0.001		$ 0.001	$ 0.001
Common stock remaining shares were cancelled	3,853,600		3,853,600		3,853,600
Number of outstanding warrants issuable shares							699,671
Net income loss	$ (3,363,022)	$ (2,612,884)	$ (5,895,644)	$ (3,364,100)	$ 17,900,000
Estimated operating expenditure for next twelve months	$ 5,800,000		$ 5,800,000		$ 5,800,000
Bone Biologics Inc [Member]
Common stock issued and outstanding per share	$ 0.0001		$ 0.0001		$ 0.0001
Common stock converted combined number of share			19,897,587
Number of outstanding warrants issuable shares	2,151,926		2,151,926		2,151,926
Number of shares issuable upon the conversion of debt			5,648,658
Payment to acquisition of business			$ 590,000